Use of indocyanine green and the HyperEye system for detecting
sentinel lymph nodes in breast cancer within a population of
European patients: a pilot study

J 2016

Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study

COUFAL, Oldřich a Vuk FAIT

Základní údaje

Originální název

Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study

Autoři

COUFAL, Oldřich (203 Česká republika, garant, domácí) a Vuk FAIT (203 Česká republika, domácí)

Vydání

World Journal of Surgical Oncology, London, BioMed Central, 2016, 1477-7819

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30200 3.2 Clinical medicine

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 1.600

Kód RIV

RIV/00216224:14110/16:00092567

Organizační jednotka

Lékařská fakulta

DOI

http://dx.doi.org/10.1186/s12957-016-1060-9

UT WoS

000391145500001

Klíčová slova anglicky

Breast cancer; Fluorescence; HyperEye; Indocyanine green; Sentinel lymph node biopsy

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 26. 4. 2017 12:35, Soňa Böhmová

Anotace

V originále

Background: Certain studies suggest that using indocyanine green (ICG) could be comparable with using radioisotopes (RI) in detecting sentinel lymph nodes (SLNs) in breast cancer. A number of these studies were performed in Asia. The objective of our pilot study was to evaluate within a European population of breast cancer patients the detection rate of SLNs using ICG and the HyperEye system and the concordance in SLNs detected using this method and the standard method involving RI and a gamma probe. Methods: Ten female patients with early-stage breast cancer (Czech Republic) indicated for partial mastectomy and SLN biopsy were subjected to standard application of RI. Before surgery, ICG was administered periareolarly in the amount of 1 ml of 0.5% solution. Sentinel lymph nodes were first detected perioperatively exclusively using ICG fluorescence and the HyperEye device (Mizuho, Japan). Only after removal of all SLNs found in this way was the standard hand-held gamma probe used to detect RI, and any potential additional SLNs not found with ICG were then extirpated. Results: In all 10 cases, at least one SLN was successfully detected using ICG. Nevertheless, in five patients, 1-4 additional SLNs were found using the gamma probe. Complete concordance in detecting SLNs therefore occurred in only one half of the cases. Metastases in SLNs were found in a total of two cases. Had we used only ICG for detection, one of these two cases would have been incorrectly evaluated as N0 (ICG false negativity). Conclusions: The study did not confirm the hypothesis that the use of ICG with the HyperEye system can currently be considered a method fully comparable with using RI and a gamma probe in a population of European patients. Although the detection rate is high, a significantly lower number of SLNs were detected using ICG than using RI (p = 0.03). Thus, there would be a higher probability for false negatives to occur in using SLN biopsy. This is caused mainly by the limited permeability of tissues to fluorescent radiation and the difficulty therefore of detecting nodes located deeper beneath the body's surface.

Citovat

COUFAL, Oldřich a Vuk FAIT. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study. World Journal of Surgical Oncology. London: BioMed Central, 2016, roč. 14, "neuvedeno", s. 1-6. ISSN 1477-7819. Dostupné z: https://dx.doi.org/10.1186/s12957-016-1060-9.

@article{1366159,
   author = {Coufal, Oldřich and Fait, Vuk},
   article_location = {London},
   article_number = {"neuvedeno"},
   doi = {http://dx.doi.org/10.1186/s12957-016-1060-9},
   keywords = {Breast cancer; Fluorescence; HyperEye; Indocyanine green; Sentinel lymph node biopsy},
   language = {eng},
   issn = {1477-7819},
   journal = {World Journal of Surgical Oncology},
   title = {Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study},
   volume = {14},
   year = {2016}
}

TY  - JOUR
ID  - 1366159
AU  - Coufal, Oldřich - Fait, Vuk
PY  - 2016
TI  - Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study
JF  - World Journal of Surgical Oncology
VL  - 14
IS  - "neuvedeno"
SP  - 1-6
EP  - 1-6
PB  - BioMed Central
SN  - 14777819
KW  - Breast cancer
KW  - Fluorescence
KW  - HyperEye
KW  - Indocyanine green
KW  - Sentinel lymph node biopsy
N2  - Background: Certain studies suggest that using indocyanine green (ICG) could be comparable with using radioisotopes (RI) in detecting sentinel lymph nodes (SLNs) in breast cancer. A number of these studies were performed in Asia. The objective of our pilot study was to evaluate within a European population of breast cancer patients the detection rate of SLNs using ICG and the HyperEye system and the concordance in SLNs detected using this method and the standard method involving RI and a gamma probe. Methods: Ten female patients with early-stage breast cancer (Czech Republic) indicated for partial mastectomy and SLN biopsy were subjected to standard application of RI. Before surgery, ICG was administered periareolarly in the amount of 1 ml of 0.5% solution. Sentinel lymph nodes were first detected perioperatively exclusively using ICG fluorescence and the HyperEye device (Mizuho, Japan). Only after removal of all SLNs found in this way was the standard hand-held gamma probe used to detect RI, and any potential additional SLNs not found with ICG were then extirpated. Results: In all 10 cases, at least one SLN was successfully detected using ICG. Nevertheless, in five patients, 1-4 additional SLNs were found using the gamma probe. Complete concordance in detecting SLNs therefore occurred in only one half of the cases. Metastases in SLNs were found in a total of two cases. Had we used only ICG for detection, one of these two cases would have been incorrectly evaluated as N0 (ICG false negativity). Conclusions: The study did not confirm the hypothesis that the use of ICG with the HyperEye system can currently be considered a method fully comparable with using RI and a gamma probe in a population of European patients. Although the detection rate is high, a significantly lower number of SLNs were detected using ICG than using RI (p = 0.03). Thus, there would be a higher probability for false negatives to occur in using SLN biopsy. This is caused mainly by the limited permeability of tissues to fluorescent radiation and the difficulty therefore of detecting nodes located deeper beneath the body's surface.
ER  -

COUFAL, Oldřich a Vuk FAIT. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study. \textit{World Journal of Surgical Oncology}. London: BioMed Central, 2016, roč.~14, ''neuvedeno'', s.~1-6. ISSN~1477-7819. Dostupné z: https://dx.doi.org/10.1186/s12957-016-1060-9.

Podrobný výpis o publikaci